CLClinicLens

Gastroenterology

[Dual therapy vs bismuth quadruple therapy in recurrent H. pylori: multicenter randomized trial]. | ClinicLens

With increasing antibiotic resistance, treatment of H. pylori infection has gradually become a challenge for clinicians. To compare the efficacy and safety of dual therapy plus bismuth (DTB) with quadruple therapy with bismuth (DBT) for the treatment of H. pylori in patients with

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.